News
Everyday diabetes medicine could treat common cause of blindness
Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the commonest cause of blindness in western countries. People with diabetes over the age of 55 years taking metformin were...
AI predicts eye damage from autoimmune drug, years before symptoms appear
A novel AI tool could transform screening for patients taking hydroxychloroquine by spotting early signs of eye damage, according to a study published in Opthalmology Retina. Researchers have devised an artificial intelligence (AI) system that can detect and predict serious...
Hope for young children with impaired eye sight caused by Albinism
The University of Southampton has been awarded over half a million pounds for groundbreaking research aimed at improving the vision of children born with Albinism. Albinism affects the production of melanin – pigment which colours eyes, skin and hair. It...
First treatment for late-stage dry AMD rejected by UK drug regulator
Leading sight loss charity the Macular Society has responded to the decision not to approve the first potential treatment for geographic atrophy (GA) or late stage dry aged-related macular degeneration. The decision is a significant setback for those affected by...
AOP welcomes focus on improved patient outcomes in Pharmacy Supervision Review Group report
Recommendations review legislative framework for the future delivery of pharmacy.
